Supplementary Figure 1 from A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma

Parul Agarwal; Matthew Guo; Kabeer Munjal; Hanfei Qi; Rose M. Parkinson; Anna K. Ferguson; Christina Anne Mitchell; Jeanne Harrison; Robert A. Anders; Elizabeth D. Thompson; Hao Wang; Ana De Jesus‐Acosta; Lei Zheng; Jin Peng He; Richard Burkhart; Amol Kumar Narang; Ben George; Elizabeth M. Jaffee; Mark M. Yarchoan; Daniel A. Laheru; Arsen Osipov

doi:10.1158/1078-0432.31719787

Supplementary Figure 1 from A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma

2026 Open access

Read full text

Authors: Parul Agarwal, Matthew Guo, Kabeer Munjal, Hanfei Qi, Rose M. Parkinson, Anna K. Ferguson, Christina Anne Mitchell, Jeanne Harrison, Robert A. Anders, Elizabeth D. Thompson, Hao Wang, Ana De Jesus‐Acosta

+9 more

Lei Zheng, Jin Peng He, Richard Burkhart, Amol Kumar Narang, Ben George, Elizabeth M. Jaffee, Mark M. Yarchoan, Daniel A. Laheru, Arsen Osipov

DOI: 10.1158/1078-0432.31719787

Cited by: 0

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research Cholangiocarcinoma and Gallbladder Cancer Studies Cancer Immunotherapy and Biomarkers

Publication details

Publication date: 13 March 2026
Language: EN